Occlusion in the Flow of New Drugs for Cardiovascular Disease

    loading  Checking for direct PDF access through Ovid

Abstract

There is a large misalignment between unmet need and both private and public investment activity in cardiovascular disease. In this paper, we quantify the magnitude of the gap, analyze a range of potential root causes in two main categories (issues of feasibility and valuation), and propose steps toward solutions to close the gap.

    loading  Loading Related Articles